Emergent BioSolutions (EBS +1.1%) has gained in morning hours after the company announced that a government agency exercised an option to extend a contract term related to its supply of Smallpox vaccine into the U.S. Strategic National Stockpile (SNS). The Office of the Assistant Secretary for Preparedness and Response (“ASPR”), part of the U.S. Department of Health and Human Services (“HHS”), has modified the contract with the exercise of the second of nine annual contract term extension options, the company said.
Image: https://seekingalpha.com
{iframe}https://seekingalpha.com/news/3715199-emergent-biosolutions-rises-after-announcing-contract-term-extension-by-hhs{/iframe}